DocumentCode :
2177193
Title :
Drug Design for AMP-Activated Protein Kinase Agonists in Silico
Author :
Chen, Chien-Yu ; Bau, Da-Tian ; Tsai, Ming-Hsui ; Hsu, Yuan-Man ; Ho, Tin-Yun ; Huang, Hung-Jin ; Chang, Yea-Huey ; Tsai, Fuu-Jen ; Tsai, Chang-Hai ; Chen, Calvin Yu-Chian
Author_Institution :
Dept. of Biol. Sci. & Technol., China Med. Univ., Taichung, Taiwan
fYear :
2009
fDate :
17-19 Oct. 2009
Firstpage :
1
Lastpage :
4
Abstract :
AMP-activated protein kinase (AMPK) is a metabolite- sensed protein kinase in various eukaryotes. The activated AMPK regulates important proteins which cause diabetes, obesity, metabolic aberrant, and also breast cancer. In this study, the yeast AMPK structure was used as a template to model the human AMPK structure. By homology modeling, the reliable AMPK structure was built, and the active binding site was defined corresponding to X-ray crystal structure of yeast AMPK By virtual screening the database. All the potent ligands had the H-bond interaction in the key residues, same as the control. Thus, we suggested the phenylamide derivates might be the potent AMPK agonists.
Keywords :
diseases; drugs; enzymes; molecular biophysics; molecular configurations; AMP-activated protein kinase agonists; H-bond interaction; X-ray crystal structure; breast cancer; diabetes; drug design; homology modeling; human AMPK structure; metabolic aberrant; metabolite-sensed protein kinase; obesity; phenylamide derivates; potent ligands; silico; virtual screening; yeast AMPK structure; Amino acids; Asia; Diabetes; Drugs; Fungi; Hospitals; Humans; Laboratories; Proteins; Sugar;
fLanguage :
English
Publisher :
ieee
Conference_Titel :
Biomedical Engineering and Informatics, 2009. BMEI '09. 2nd International Conference on
Conference_Location :
Tianjin
Print_ISBN :
978-1-4244-4132-7
Electronic_ISBN :
978-1-4244-4134-1
Type :
conf
DOI :
10.1109/BMEI.2009.5304901
Filename :
5304901
Link To Document :
بازگشت